期刊文献+

还原型谷胱甘肽对早期2型糖尿病肾病氧化应激状态的影响 被引量:6

Effect of reduced glutathione on oxidative stress in the patients with type 2 diabetic nephropathy
下载PDF
导出
摘要 目的:探讨还原型谷胱甘肽对早期2型糖尿病肾病氧化应激状态的影响。方法:2型糖尿病肾病Ⅲ期患者72例,随机分为:对照组36例,给予常规治疗;治疗组36例,对照组在对照组的基础上加还原型谷胱甘肽治疗,检测相关指标。结果:经还原型谷胱甘肽治疗后,患者hs-CRP、IL-6、TNF-α、Hcy、24hmALB水平明显降低治疗前(P<0.05)。治疗后,治疗组血清炎症标志物hs-CRP、TNF-α、Hcy水平,明显低于对照组,差异有统计学意义(P<0.05)。结论:早期2型糖尿病肾病存在氧化应激状态,还原型谷胱甘肽可改善氧化应激,减少尿mALB排泄。 Objective: To study the effect of reduced glutathione on oxidative stress in the patients with type 2 diabetic nephropathy. Methods: 72 patients with type 2 diabetic nephropathy were en-rolled,of which 36 were put into the control group and the left 36 were in the treatment group ran-domly. Patients in treatment group received reduced glutathione and routine insulin therapy,while patients in control group took routine insulin therapy only. Based on which, the indicators involved would be determined. Results: With the treatment of reduced glutathione, the serum hs-CRP, IL- 6, TNF-a, Hcy level and 24-hour urine microalbumi significantly increased(P〈0.05). And serum levels of inflammatory markers hs-CRP, TNF-α, Hcy level significantly decreased in treatment group vs the control group(P〈0. 05). Conclusions: Microinflammation exists in the patients with type 2 diabetic nephropathy, and reduced glutathione can obviously improve the oxidative stress and decreased urinary mALB excretion.
出处 《华夏医学》 CAS 2013年第4期670-673,共4页 Acta Medicinae Sinica
关键词 还原型谷胱甘肽 氧化应激 糖尿病肾病 Reduced glutathione oxidative stress diabetic nephropathy
  • 相关文献

参考文献11

二级参考文献49

共引文献217

同被引文献65

  • 1安娜,刘惠兰,王英.2型糖尿病肾病大鼠肾小管间质病变及TGF-β1、HGF和CTGF表达的变化及意义[J].首都医科大学学报,2008,29(3):315-320. 被引量:12
  • 2肖云,肖洁,谢辉,李钰青,佘晓芬,吴峻.灯盏花素联合还原型谷胱甘肽治疗糖尿病肾病的临床疗效[J].中国老年学杂志,2014,34(8):2042-2044. 被引量:23
  • 3杨莹,吴于滨,宋滇平.氧化应激与糖尿病肾病的分子机制[J].昆明医学院学报,2007,28(02B):100-103. 被引量:1
  • 4中华医学会糖尿病分会.中国2型糖尿病防治指南[M].北京:北京医科大学出版社,2007:33.
  • 5舒红.还原型谷胱甘肽的临床应用[J].黑龙江医学,2007,31(11):840-841. 被引量:10
  • 6Delgado M A, Zamorano J L. Atorvastatin calcium plus amlodipine for the treatment of hypertension [ J ]. Expert Opin Pharmacother, 2012,13 ( 18 ) :2673-2685.
  • 7Kotlega D, Ciecwiez S, Turowska K J, et al. Pathogenet- ic justification of statin use in isehaemie stroke prevention according to inflammatory theory in development of ather- oselerosis[ J]. Neurol Neurochir Pol, 2012,46 (2) : 176- 183.
  • 8Padhy B M, Yadav R, Gupta Y K. Hypolipidaemic and anti-inflammatory effects of fixed dose combination of atorvastatin plus ezetimibe in Indian patients with dyslipi- daemia[ J]. Singapore Med J, 2013,54 (2) :90-95.
  • 9Yamagishi S, Fukami K, Ueda S, et al. Molecular mech-anism of diabetic nephropathy and its therapeutic inter- vention [ J ]. Curr Drug Targets, 2007,8 ( 8 ) : 952-959.
  • 10Goh S Y, Cooper M E. Clinical review: The role of ad- vanced glyeation end products in progression and compli- cations of diabetes[ J ]. J Clin Endocrinol Metab, 2008, 93(4) :1143-1152.

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部